Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.95p
   
  • Change Today:
      0.100p
  • 52 Week High: 14.25
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 7,632,103
  • Market Cap: £19.75m
  • Beta: 0.04

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
45.88% below the market average45.88% below the market average45.88% below the market average45.88% below the market average45.88% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
89.86% above the market average89.86% above the market average89.86% above the market average89.86% above the market average89.86% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Price Chg 3m
48.41% above the market average48.41% above the market average48.41% above the market average48.41% above the market average48.41% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
34.88% above the sector average34.88% above the sector average34.88% above the sector average34.88% above the sector average34.88% above the sector average
Momentum 20
12.23% below the market average12.23% below the market average12.23% below the market average12.23% below the market average12.23% below the market average
11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average69.27% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
56.43% below the market average56.43% below the market average56.43% below the market average56.43% below the market average56.43% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
78.85% below the market average78.85% below the market average78.85% below the market average78.85% below the market average78.85% below the market average
36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average36.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.54% below the market average35.54% below the market average35.54% below the market average35.54% below the market average35.54% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Cash
65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.95p
Change Today 0.100p
% Change 2.60 %
52 Week High 14.25
52 Week Low 2.40
Volume 7,632,103
Shares Issued 500.00m
Market Cap £19.75m
Beta 0.04

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average53.97% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
84.08% below the market average84.08% below the market average84.08% below the market average84.08% below the market average84.08% below the market average
61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
10:44 29,130 @ 3.92p
10:41 67,551 @ 3.96p
10:41 9,171 @ 3.96p
10:40 50,000 @ 3.96p
10:39 300,000 @ 3.94p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page